Ethics approval
The trial was approved by the regional ethics committee (REK Sør-Øst 2016/1223) and by the Norwegian Medicines Agency. All patients provided written informed consent. The trial was conducted according to the Declaration of Helsinki and the guidelines for Good Clinical Practice.